DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
10,300
Employees10,300
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
10,300
Employees10,300

DXCM Key Statistics

Market cap
24.39B
Market cap24.39B
Price-Earnings ratio
34.80
Price-Earnings ratio34.80
Dividend yield
Dividend yield
Average volume
5.83M
Average volume5.83M
High today
High today
Low today
Low today
Open price
$61.45
Open price$61.45
Volume
0.00
Volume0.00
52 Week high
$93.25
52 Week high$93.25
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

With a market cap of 24.39B, DexCom(DXCM) trades at $61.68. The stock has a price-to-earnings ratio of 34.80.

DexCom(DXCM) stock opened on 2025-11-28 at $61.45. The price climbed to — and dipped to —.

The DexCom(DXCM)'s current trading volume is 0, compared to an average daily volume of 5.83M.

During the past year, DexCom(DXCM) stock moved between $54.11 at its lowest and $93.25 at its peak.

During the past year, DexCom(DXCM) stock moved between $54.11 at its lowest and $93.25 at its peak.

DXCM News

TipRanks 3d
OIG report looks positive for DexCom, says BofA

After the Office of Inspector General report on Medicare payments for continuous glucose monitors and supplies came out, BofA noted that the report is just the...

Simply Wall St 7d
What DexCom's FDA-Cleared G7 15 Day CGM and Smart Basal Integration Means For Shareholders

DexCom announced the launch of its FDA-cleared Dexcom G7 15 Day Continuous Glucose Monitoring system for adults with diabetes in the United States as of Decembe...

What DexCom's FDA-Cleared G7 15 Day CGM and Smart Basal Integration Means For Shareholders
Nasdaq 7d
Friday Sector Leaders: Healthcare, Services

The best performing sector as of midday Friday is the Healthcare sector, higher by 0.6%. Within that group, Intuitive Surgical Inc (Symbol: ISRG) and DexCom Inc...

Friday Sector Leaders: Healthcare, Services

Analyst ratings

82%

of 33 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.